Professional Documents
Culture Documents
Dr. N. She ar
Najwa Esmail, Sab rina Ing and Marc Ke rb a, e d itors
Che ryl We in, associate e d itor
HISTORY
❏ age , race , occup ation, hob b ie s
❏ d e tails of skin e rup tion
• location
• onse t
• p e rsiste nt/inte rmitte nt
• factors affe cting e rup tion (aggravating/re lie ving factors)
❏ associate d skin symp toms (itchine ss/b urning/p ain/d ry/d ischarge )
❏ p ast history of skin e rup tions
❏ associate d syste mic symp toms
❏ e nvironme ntal and p sychological factors
❏ alle rgie s, me d ications
❏ p ast me d ical history
❏ family history of skin and inte rnal d ise ase
PHYSICAL EXAM
❏ d istrib ution
❏ colour
❏ typ e of le sion (se e morp hological d e finitions)
❏ arrange me nt (annular, line ar, e tc...)
❏ re me mb e r to e xamine hair, mucous me mb rane s and nails
DEFINITIONS
PRIMARY MORPHOLOGICAL LESIONS
Table 1. Type s of Le s ions
< 1 cm diame te r ≥ 1 cm diame te r
rais e d s upe rficial le s ion papule (e.g. wart) plaque (e.g. psoriasis)
e le vate d fluid fille d le s ions vesicle (e.g. HSV) bulla (e.g. bullous pemphigoid)
❏ p ustule : a ve sicle that contains p urule nt e xud ate (white , ye llow, gre e n)
(e .g. p ustular acne )
❏ e rosion: a d isrup tion of the skin involving the e p id e rmis alone
❏ ulce r: a d isrup tion of the skin that e xte nd s into the d e rmis or d e e p e r
❏ whe al: a sp e cial form of p ap ule or p laq ue that is b lanchab le and
transie nt, forme d b y e d e ma in the d e rmis (e .g. urticaria)
❏ scar: re p lace me nt fib rosis of d e rmis and sub cutane ous tissue
• Diane -35 OCP (cyp rote rone ace tate + e thinyl e strad iol)
• high-e stroge n OCP
❏ d iffe re ntial d iagnosis
• rosace a
• folliculitis
• p e rioral d e rmatitis
ROSACEA (s e e Colour Atlas A6)
❏ a chronic and re curre nt inflammatory d isord e r of the p ilose b ace ous
units and vasculature of the face characte rize d b y te langie ctase s,
flushing (d ue to cap illary vasod ilation), p ap ule s, and p ustule s
❏ d iffe re ntiate d from acne b y its ab se nce of come d one s
• F>M, 30-50 ye ars old
• symme trical; fore he ad , che e ks, nose , chin, e ye s
• may ge t conjunctivitis, b le p haritis, e p iscle ritis, or ke ratitis
• may d e ve lop rhinop hyma (nose e nlarge me nt)
❏ p rolonge d course common, re curre nce s common, may d isap p e ar
sp ontane ously
❏ unknown p athoge ne sis
❏ e xace rb ating factors
• he at, cold , wind , sun, stre ss, d rinking hot liq uid s, alcohol,
caffe ine , sp ice s
❏ tre atme nt
• top ical
• antib iotics (me tronid azole 0.75% ge l or cre am, clind amycin
or e rythromycin have anti-inflammatory me chanisms)
• syste mic
• te tracycline or e rythromycin 250 mg q id the n as ne e d e d
• alte rnative s: minocycline
• othe rs
• lase rs for te langie ctase s
• p lastic surge ry or lase r for rhinop hyma
• camouflage make up for e rythe ma
❏ d iffe re ntial d iagnosis
• SLE
• carcinoid synd rome
• acne vulgaris
• p e rioral d e rmatitis
PERIORAL DERMATITIS
❏ d iscre te e rythe matous microp ap ule s that ofte n b e come conflue nt
forming inflammatory p laq ue s on p e rioral and p e riorb ital skin
❏ sub se t of acne iform cond itions
• initial le sions usually in nasolab ial fold s, symme try common, rim
of sp aring around ve rmilion b ord e r of lip s
• 15 to 40 ye ar old
• fe male s p re d ominantly
• can b e aggravate d b y p ote nt top ical (fluorinate d ) corticoste roid s
❏ tre atme nt
• top ical
• me tronid azole 0.75% ge l or cre am to are a b id
• syste mic
• te tracycline 500 mg b id until cle ar, the n 500 mg d aily for
1 month, the n 250 mg d aily for 1 ad d itional month
ATOPIC DERMATITIS
(s e e Colour Atlas A3)
❏ sub acute and chronic e cze matous re action cause d b y Typ e I
(IgE-me d iate d ) hyp e rse nsitivity re action (re le ase of histamine )
p rod ucing p rolonge d se ve re p ruritus
❏ incre ase d p e rsonal or family history of atop y
(asthma, e cze ma, hay fe ve r)
• 3% of infants – 50% cle ar b y age 13, fe w p e rsist > 30 ye ars of age
• p olyge nic inhe ritance : one p are nt > 60% chance for child ;
two p are nts > 80% chance for child
❏ associate d find ings
• ke ratosis p ilaris (hyp e rke ratosis of hair follicle s, “chicke n skin”)
• xe rosis
• atop ic p alms: p romine nt p almar cre ase s
• inflammation, liche nification, e xcoriations are 2º to re le ntle ss
scratching
Infant (onse t at 2-6 months old ) Face , scalp , e xte nsor surface s
Child hood (>18 months) Fle xural surface s
Ad ult Hand s, fe e t, fle xure s, ne ck, e ye lid s, fore he ad , face , wrists
❏ tre atme nt
• b ath ad d itive (Ave e no oatme al) followe d b y ap p lication of
unsce nte d e mollie nts, or me nthol (cooling age nt)
• top ical corticoste roid s with oral antihistamine s
• avoid p rolonge d p ote nt d ose ; hyd rocortisone cre am for
mainte nance
• alte rnate with lub ricants or tar solution
• antib iotic the rap y if 2º infe ction b y S. aureus
• avoid syste mic corticoste roid s
SEBORRHEIC DERMATITIS
(s e e Colour Atlas A4)
❏ gre asy, e rythe matous, ye llow, non-p ruritic scaling p ap ule s and p laq ue s
occurs in are as rich in se b ace ous gland s
• site s: scalp , e ye b rows, e ye lashe s, b e ard , face (flush are as,
b e hind e ars, fore he ad ), trunk, b od y fold s, ge nitalia
• p ossib le e tiologic association with the ye ast Pityrosp orum ovale
• incre ase d incid e nce in AIDS and Parkinson’s p atie nts
❏ tre atme nt
• face : non-fluorinate d hyd rocortisone cre am
• scalp : salicylic acid in olive oil (to re move scale ),
2% ke toconazole shamp oo (Nizarole ), low p ote ncy ste roid lotion
STASIS DERMATITIS
(s e e Colour Atlas A1)
❏ p e rsiste nt skin inflammation of the lowe r le gs with a te nd e ncy toward
b rown p igme ntation, e rythe ma, and scaling
• commonly associate d with ve nous insufficie ncy
• comp lications: se cond ary b acte rial infe ctions, ulce ration
❏ tre atme nt
• sup p ort stocking
• re st and e le vate le gs
• moisturize r to tre at xe rosis
• mild top ical corticoste roid s to control inflammation
• surgical ve in strip p ing for cosme tic re asons only
NUMMULAR DERMATITIS
❏ annular coin-shap e d p ruritic p laq ue s
• d ry, scaly, liche nifie d
• ofte n associate d with atop y and d yshyd rotic e cze ma
❏ tre atme nt
• p ote nt corticoste roid ointme nt b id or intale sional triamcinolone
inje ction if se ve re
DYSHYDROTIC DERMATITIS
❏ p ap ulove sicular d e rmatitis of hand and foot; may b e come liche nifie d
with scaly p laq ue s
❏ misnome r – p athop hysiology is NOT re late d to swe ating
❏ tre atme nt
• top ical
• high p ote ncy corticoste roid with saran wrap occlusion to
incre ase p e ne tration
• intrale sional triamicinolone
• syste mic
• p re d nisone in se ve re case s
• antib iotics for 2º S. aureus infe ction
DIAPER DERMATITIS
(se e Pe d iatrics Note s)
BACTERIAL
❏ ofte n involve the e p id e rmis, d e rmis, hair follicle s or p e riungual re gion.
❏ may also b e syste mic
SUPERFICIAL (EPIDERMAL)
Impe tigo Vulgaris (s e e Colour Atlas F5)
❏ acute p urule nt infe ction which ap p e ars ve sicular and p rogre sse s to
crusting (crust is gold e n ye llow and ap p e ars stuck on)
• age nt: GABHS, S. aureus, or b oth
• site s: commonly involve s the face , arms, le gs and b uttocks
• affe cte d : p re school and young ad ults living in crowd e d
cond itions, p oor hygie ne , ne gle cte d minor trauma
• comp lication: p ost-stre p . glome rulone p hritis
❏ tre atme nt
• re move crusts and use saline comp re sse s, p lus top ical antise p tic
soaks b id
• top ical antib acte rials such as mup irocin or fucid in, continue d for
7-10 d ays afte r re solution
• syste mic antib iotics such as cloxacillin or ce p hale xin
❏ d iffe re ntial d iagnosis
• infe cte d e cze ma, he rp e s simp le x, varice lla
Bullous Impe tigo
❏ scatte re d , thin walle d b ullae arising in normal skin and containing cle ar
ye llow or slightly turb id fluid with no surround ing e rythe ma
• age nt: S. aureus group II e lab orating e xfoliating toxin
• site s: trunk, inte rtriginous are as, face
• affe cte d : ne onate s and old e r child re n, e p id e mic e sp e cially in
d ay care
• comp lication: high le ve ls of toxin in immunocomp romise d or
young child re n may le ad to ge ne ralize d skin p e e ling or
stap hylococcal scald e d skin synd rome (SSSS)
❏ tre atme nt
• cloxacillin
• top ical antib acte rials such as fucid in and mup irocin,
continue d for 7-10 d ays
Erythras ma
❏ infe ction of the stratum corne um that manife sts as a sharp ly
d e marcate d , irre gularly shap e d b rown, scaling p atch
• age nt: Coryne b acte rium minutissimum
• site s: inte rtriginous are as of groin, axillae , inte rglute al fold s,
sub mammary, toe s
• affe cte d : ob e se , mid d le -age d , b lacks, d iab e tics, living in warm
humid climate
• d iagnosis: “coral-re d ” fluore sce nce und e r Wood ’s light (365 nm)
b e cause of a wate r-solub le p orp hyrin
❏ tre atme nt
• e conazole cre am ap p lie d b id and showe rs with p ovid one -iod ine
soap
• e rythromycin (250 mg q id for 14 d ays) for re fractory case s or
re curre nce s
❏ d iffe re ntial d iagnosis
• tine a cruris (p ositive scrap ing for hyp hae )
• se b orrhe ic d e rmatitis (no fluore sce nce )
DEEPER (DERMAL)
Table 4. Comparis on of Erys ipe las and Ce llulitis
may be confluent, but well demarcated and poorly demarcated, not uniformly raised
raised, often with vesicles
systemic symptoms: fever, chills, systemic symptoms less likely (but may
headache, weakness have fever, leukocytosis and lymphadenopathy)
more serious
m check for history of trauma, bites, saphenous vein graft, etc..., but often no inciting cause identified
m rarely culture bacteria by skin/blood culture; clinical diagnosis. If suspecting necrotizing fasciitis,
do immediate biopsy and frozen section histopathology
m DDx: DVT (less red, less hot, smoother), superficial phlebitis, RSD
HAIR FOLLICLES
Supe rficial Folliculitis
❏ sup e rficial infe ction of the hair follicle
❏ p se ud ofolliculitis: inflammation of follicle d ue to friction, irritation or
occlusion
❏ acute le sion consists of a sup e rficial p ustule surround ing the hair
• can occur on face (Staphylococcus most common), b e ard are a,
scalp or le gs, trunk (Pseudomonas), or b ack (Candida)
• common in AIDS
❏ tre atme nt
• top ical antib acte rial (fucid in, mup irocin or e rythromycin),
• oral cloxacillin for 7-10d
• mup irocin for S. aure us in nostril and on involve d hairy are a
Furuncle s (Boils )
❏ re d , hot, te nd e r, inflammatory nod ule s involving sub cutane ous tissue
that e volve s from a Staphylococcus folliculitis
• occurs whe re the re are hair follicle s and in are as of friction
and swe at (nose , ne ck, face , axillae , b uttocks)
❏ if re curre nt, rule out d iab e te s or hid rad e nitis sup p urativa (if in groin
or axillae )
Carbuncle s
❏ d e e p se ate d conglome rate of multip le coale scing furuncle s
❏ tre atme nt
• incise and d rain large carb uncle s to re lie ve p re ssure and p ain
• if afe b rile : hot we t p acks, top ical antib iotic
• if fe b rile /ce llulitis: culture b lood and asp irate p ustule s
(Gram stain and C&S)
• cloxacillin for 1 to 2 we e ks
PERIUNGUAL REGION
Paronychia
❏ inflammation around nail
• can cause nail d ystrop hy
• acute : S. aureus, Streptococcus
• chronic: C. albicans
❏ tre atme nt
• avoid e xp osure to moisture
• top ical fucid in or clotrimazole
OTHERS
Syphilis
❏ se xually transmitte d infe ction cause d b y Treponema pallidum
characte rize d b y a p ainle ss ulce r (chancre )
❏ following inoculation b e come s a syste mic infe ction with se cond ary
and te rtiary stage s
❏ p rimary syp hilis (s e e Colour Atlas F11)
• single re d , ind urate d , PAINLESS, round /oval, ind ole nt, chancre
(b uttonlike p ap ule ) that d e ve lop s into
p ainle ss ulce r with raise d b ord e r and scanty se rous e xud ate
• chancre d e ve lop s at site of inoculation afte r 3 we e ks of
incub ation and he als in 4-6 we e ks
• re gional non-te nd e r lymp had e nop athy ap p e ars < 1 we e k afte r
onse t of chancre
• VDRL ne gative
• d arkfie ld e xamination (for p rimary) - sp iroche te in tissue fluid
from chancre or lymp h nod e asp irate
• M:F = 2:1
• tre atme nt: b e nzathine p e nicillin G 2.4 million units IM
• d iffe re ntial d iagnosis
• chancroid : p ainful
• HSV: multip le le sions
❏ se cond ary syp hilis (s e e Colour Atlas F13)
• ap p e ars 2-10 we e ks afte r initial chancre , and 2-6 months afte r
p rimary infe ction
• ge ne ral e xam: ge ne ralize d lymp had e nop athy, sp le nome galy,
+/– fe ve r
• le sions he al in 1-5 we e ks, and may re cur for 1 ye ar
• typ e s of le sions
1. macule s and p ap ule s, round to oval, flat top , scaling,
non-p ruritic, sharp ly d e fine d , circular (annular) rash
• trunk, he ad , ne ck, p alms, sole s, mucous me mb rane s
• d iffe re ntial d iagnose s: p ityriasis rose a, tine a corp oris, d rug
e rup tions, liche n p lanus
2. cond yloma lata: moist p ap ule s around ge nital/p e rianal re gion
• e xud ate te e ming with sp iroche te s
• d iffe re ntial d iagnosis includ e s cond yloma acuminata
3. mucous p atche s: mace rate d p atche s mainly found in oral
mucosa
• associate d find ings: p haryngitis, iritis, p e riostosis,
“acute illne ss” synd rome - he ad ache , chills, fe ve r,
arthralgia, myalgia, malaise , p hotop hob ia
• VDRL p ositive
• FTA-ABS +ve ; –ve afte r 1 ye ar following ap p e arance of chancre
• TPI +ve ; d arkfie ld +ve in all se cond ary syp hilis e xce p t macular
e xanthe m
• se rologic te st may b e –ve if und ilute d se rum, or if HIV-infe cte d
• tre atme nt as for p rimary syp hilis
VIRAL
He rpe s Simple x (s e e Colour Atlas F12)
❏ group e d ve sicle s (he rp e tiform arrange me nt) on an e rythe matous
b ase on skin or mucous me mb rane s
• transmitte d via contact with e rup te d ve sicle s
• p rimary
• child re n and young ad ults
• usually asymp tomatic
• may have high fe ve r, re gional lymp had e nop athy, malaise
• se cond ary
• re curre nt form se e n in ad ults
• p rod rome of tingling, p ruritus, p ain
• much more commonly d iagnose d than p rimary
HSV I
❏ re curre nt on face , lip s
❏ rare ly on mucous me mb rane s (rule out ap hthous ulce r)
❏ virus in p oste rior root ganglion (Gasse rian ganglion of trige minal ne rve ,
sacral ganglion)
❏ re activate d b y: sunlight, fe ve r, me nstruation, stre ss, up p e r re sp iratory
infe ction, p hysical trauma
❏ d iffe re ntial d iagnosis
• imp e tigo
• e cze ma
HSV II
❏ incub ation 2-20 d ays
❏ gingivostomatitis (e ntire b uccal mucosa involve d with e rythe ma and
e d e ma of gingiva)
❏ vulvovaginitis (e d e matous, e rythe matous, e xtre me ly te nd e r, p rofuse
vaginal d ischarge )
❏ ure thritis (wate ry d ischarge in male s)
❏ re curre nt on vulva, vagina, p e nis, lasting 5-7 d ays
❏ 8% risk of transmission to ne onate via b irth canal if mothe r is
asymp tomatic
❏ d iagnosis confirme d with –ve d arkfie ld , –ve se rology for syp hilis,
–ve b acte rial culture s
• Tzanck sme ar shows multinucle ate d giant e p ithe lial ce lls
with Gie msa stain
• tissue culture and EM on ve sicular fluid
• skin b iop sy (intrae p id e rmal, b allooning d e ge ne ration, giant ce lls)
❏ antib od y titre s incre ase 1 we e k afte r p rimary infe ction, howe ve r,
incre ase in titre s are not d iagnostic of re curre nce
De rmatology 10 MCCQE 2000 Re vie w Note s and Le cture Se rie s
INFECTIONS . . . CONT. Note s
❏ tre atme nt
• rup ture ve sicle with ste rile ne e d le
• te p id we t d re ssing with aluminum sub ace tate solution,
Burow’s comp re ssion, or b e tad ine solution
• acyclovir: 200 mg PO, 5 time s a d ay for 10 d ays for 1st e p isod e
• top ical the rap y is ge ne rally not as e ffe ctive
• famciclovir and valacyclovir may b e sub stitute d
❏ comp lications
• d e nd ritic corne al ulce rs
• stromal ke ratitis
• e rythe ma multiforme
• he rp e s simp le x e nce p halitis
• HSV infe ction on atop ic d e rmatitis causing Kap osi’s varice lliform
e rup tion (e cze ma he rp e ticum)
Clinical Pe arl
❏ In He rpe s Zos te r, antiviral tre atme nt mus t be s tarte d within
72 hours of the ons e t of ras h unle s s ophthalmic involve me nt
Hand-Foot-and-Mouth Dis e as e
❏ gre y ve sicle s in p aralle l alignme nt to p almar and p lantar cre ase s of
hand s, fe e t and d iap e r are a with a p ainful ulce rative e xanthe m ove r
b uccal mucosa and p alate
• young child re n ofte n p re se nting with re fusal to e at
• Coxsackie A16, highly contagious
• 3-6 d ay incub ation, re solve s in 7-10 d ays
❏ tre atme nt
• xylocaine ge l as analge sic
❏ tre atme nt
• p od op hyllin (contraind icate d in p re gnancy)
• liq uid nitroge n, e le ctrocaute ry
• trichloroace tic acid (80-90%), intrale sional inte rfe ron
• surge ry only ne e d e d for giant le sions
❏ d iffe re ntial d iagnosis
• cond ylomata lata (se cond ary syp hilitic le sion, d arkfie ld
strongly + ve )
• molluscum contagiosum
• liche n p lanus
• p e arly p e nile p ap ule s
DERMATOPHYTES
(SUPERFICIAL FUNGAL INFECTION OF SKIN)
❏ cause d b y Trichop hyton, Microsp orum, Ep id e rmop hyton
❏ live on d e ad sup e rficial skin b y d ige sting ke ratin the re fore
re sult in scaly skin, b roke n hairs and crumb ling nails
❏ d iagnose using skin scrap ings, hair, and nail clip p ings analyze d with
KOH p re p (since the se fungi live as mold s, look for hyp hae ,
and myce lia)
❏ ge ne ral p rincip le s of tre atme nt
• top icals are not first line the rap y for all d e rmatop hyte s
• top icals may b e use d as first line age nts for tine a corp oris/cruris
and tine a p e d is (inte rd igital typ e )
• main top icals are clotrimazole or te rb inafine
• othe rwise tre at orally with te rb inafine (Lamisil) or itraconazole
(Sp oranox)
• itraconazole is a P-450 inhib itor. It alte rs me tab olism
of non-se d ating antihistamine s, cisap rid e , d igoxin, and
HMG CoA re d uctase inhib itors
PARASITIC
Scabie s (s e e Colour Atlas F2)
❏ a transmissib le p arasitic skin infe ction (Sarcop te s scab ie i, a mite ),
characte rize d b y sup e rficial b urrows, inte nse p ruritus and se cond ary
infe ction
• se cond ary le sions: small urticarial cruste d p ap ule s,
e cze matous p laq ue s, e xcoriations
• site s: axillae , cub itus, wrist, sid e of p alm, we b sp ace s, groin,
b uttocks, b ack of ankle , toe s, p e nis
• se xual p romiscuity, crowd ing, p ove rty, nosocomial
• intractab le p ruritus worse at night (mite more active ; p ruritus is
also worse at night)
• ad ults: scalp , face , up p e r b ack sp are d
• infants: scalp , face , p alms/sole s involve d
• immunocomp romise d : Norwe gian Scab ie s =
Cruste d Scab ie s; all ove r b od y
• scab ie s mite re main alive 2-3 d ays on clothing/she e ts
• incub ation = 1 month, the n b e gin to itch
• re -infe ction followe d b y hyp e rse nsitivity in 24 hours
• microscop ic e xamination of root and conte nt of b urrow with KOH
for mite , e ggs, fe ce s
❏ tre atme nt
• b athe the n ap p ly Pe rme thrin 5% cre am (i.e . Nix) or Kwe llad a
from he ad (not ne ck) d own to sole s of fe e t (must b e le ft on for
8 hours)
• Nix is p re fe rre d in child re n (se izure s re p orte d with Kwe llad a)
• may re q uire se cond tre atme nt 7 d ays afte r first tre atme nt
• change und e rwe ar and line ns
• +/– antihistamine
• tre at family and contacts
• p ruritus may p e rsist for 2-3 we e ks d ue to p rolonge d
hyp e rse nsitivity re action
❏ d iffe re ntial d iagnosis
• d e rmatitis he rp e tiformis: se e ve sicle s, urticaria, e osinop hilia, no b urrows
• aste atotic e cze ma (“winte r itch”)
• ne urotic e xcoriation
PLAQUE PSORIASIS
❏ a common chronic and re curre nt d ise ase characte rize d b y d ry,
we ll-circumscrib e d , silve r scale s ove r e rythe matous p ap ule s/p laq ue s,
mostly at site s of re p e ate d trauma
• site s: scalp , e xte nsor surface s of e lb ows and kne e s, trunk, nails,
p re ssure are as
• worse in winte r (lack of sun and humid ity)
• multifactorial inhe ritance : 30% with family history and HLA marke rs
❏ p athoge ne sis: d e cre ase e p id e rmal transit time from b asal to horny
laye rs and shorte ne d ce ll cycle of p soriatic and normal skin
❏ Koe b ne r p he nome non (isomorp hic re sp onse ): ind uction of ne w le sion
b y injury
❏ Ausp itz’s sign: b le e d s from minute p oints whe n scale is re move d
❏ e xace rb ating factors: d rugs (lithium, e thanol, chloroq uine ,
b e ta-b locke rs), sunlight, stre ss, ob e sity
❏ tre atme nt
• top ical and syste mic
anthralin .1%, .2%, .4% increase cell turnover stains and irritates normal skin
ERYTHRODERMIC PSORIASIS
❏ ge ne ralize d e rythe ma with fine d e sq uamative scale on surface , with
island s of sp are d skin
❏ may p re se nt in p atie nt with p re vious mild p laq ue p soriasis
• aggravating factors: lithium, b e ta-b locke rs, NSAIDs, antimalarials,
p hototoxic re action, infe ction
• associate d symp toms: worse arthralgia, se ve re p ruritus
❏ tre atme nt
• hosp italization, b e d re st, IV fluid s, monitor fluid and lyte s
• tre at und e rlying aggravating cond ition
• me thotre xate
• PUVA and re tinoid s
PUSTULAR PSORIASIS
❏ sud d e n onse t of e rythe matous macule s and p ap ule s which e volve into
p ustule s rap id ly; can b e ge ne ralize d (von Zumb usch typ e ) or localize d
(acrop ustulosis or p ustulosis of p alms and sole s)
❏ uncommon
• p atie nt may have no history of p soriasis, or was re ce ntly
inap p rop riate ly withd rawn from ste roid the rap y. It also may
occur in the 3rd trime ste r of p re gnancy (imp e tigo he rp atiformis)
• associate d symp toms: fe ve r, arthralgias, d iarrhe a, 8 WBCs
❏ tre atme nt
• b e d re st, withd raw e xace rb ating me d ications, monitor lyte s
• me thotre xate and e tre tinate (start with low d ose )
• localize d PUVA for p ustulosis of p alms and sole s
PSORIATIC ARTHRITIS
❏ 5 cate gorie s
• asymme tric oligoarthrop athy
• DIP joint involve me nt is p re d ominant
• rhe umatoid p atte rn – symme tric p olyarthrop athy
• p soriatric arthritis mutilans
• p re d ominant sp ond ylitis or sacroilitis
s calp dry, scaling, well demarcated, reddish, • tar shampoo followed by betamethasone
lichenified plaques (no hair loss), mild valerate 0.1% lotion biweekly
to severe itching, sunlight does not • If severe (thick plaques)
cause remission remove plaque with 10% salicylic acid in mineral oil
and cover with plastic cap overnight (1-3 treatments)
• fluocinolone cream/lotion with cap overnight
• maintenance with scalp lotion (clobetasol
propionate 0.05%)
LICHEN PLANUS
❏ acute or chronic inflammation of mucous me mb rane s or skin
characte rize d b y violace ous, shiny, p ruritic p ap ule s top p e d with
Wickham’s striae (fine white line s); milky white p ap ule s in mouth
• site s: fle xor surface of wrists, lumb ar re gion, shins, e ye lid s, scalp ,
b uccal mucosa, tongue , lip s, nails
• scalp le sions associate d with alop e cia
• sp ntane ously re solve s in we e ks or lasts for ye ars (mouth and shin
le sions)
• mne monic “6 P’s: Purp le , Pruritic, Polygonal, Pe rip he ral, Pap ule s,
Pe nis
• p re cip itating factor: se ve re e motional stre ss
• associate d with he p atitis C
❏ tre atme nt
• top ical corticoste roid s with occlusion or intrad e rmal
ste roid inje ctions
• short course s of oral p re d nisone (rare ly)
• PUVA for ge ne ralize d or re sistant case s
• oral re tinoid s for e rosive liche n p lanus in mouth
❏ d iffe re ntial
• skin
• d rug e rup tion (chloroq uine or gold salts)
• liche noid graft vs. host d ise ase
• lup us e rythe matosus
• contact with colour film d e ve lop me nt che micals
• mucous me mb rane s
• le ukop lakia
• thrush
• HIV associate d hairy le ukop lakia
• lup us e rythe matosus
PEMPHIGUS VULGARIS
❏ autoimmune b liste ring d ise ase characte rize d b y flaccid ,
non-p ruritic b ullae /ve sicle s on an e rythe matous b ase
❏ e tiology
• IgG p rod uce d against e p id e rmal d e smogle in 3 le ad ing to
acantholysis (e p id e rmal ce lls se p arate d from e ach othe r)
p rod ucing intrae p id e rmal b ullae
• associate d with thymoma, myasthe nia gravis, malignancy,
D-p e nicillamine
❏ history
• 40-60 ye ars old , p atie nts are ofte n Je wish or Me d ite rrane an
❏ p hysical
• may p re se nt with e rosions and se cond ary b acte rial infe ction
• site s: mouth (90%), scalp , face , che st, axillae , groin, umb ilicus
• Nikolsky’s sign: b ulla e xte nd s with finge r p re ssure
❏ d iagnosis
• immunofluore sce nce shows IgG and C3 d e p osite d in
e p id e rmal inte rce llular sp ace s
❏ course
• mouth le sions, months late r skin le sions; first
localize d (6-12 months) the n ge ne ralize d
• le sions he al with hyp e rp igme ntation b ut no scar
• may b e fatal unle ss tre ate d with immunosup p re ssive age nts
❏ tre atme nt
• p re d nisone 2.0-3.0 mg/kg until no ne w b liste rs, the n
1.0-1.5 mg/kg until cle ar, the n tap e r
• ste roid sp aring age nts - azathiop rine , p lasmap he re sis,
me thotre xate , gold , cyclop hosp hamid e
BULLOUS PEMPHIGOID
❏ chronic autoimmune b ullous e rup tion characte rize d b y p ruritic, te nse ,
sub e p id e rmal b ullae
❏ e tiology
• IgG p rod uce d against b ase me nt me mb rane
• associate d with malignancy in some
❏ history
• 60-80 ye ars old
❏ p hysical
• site s: fle xor asp e ct of fore arms, axillae , me d ial thighs, groin,
ab d ome n, mouth (33%)
❏ d iagnosis
• d ire ct immunofluore sce nce shows d e p osition of IgG and C3
at b ase me nt me mb rane
• anti-b ase me nt me mb rane antib od y (IgG)
❏ course
• he aling without scars if no infe ction
❏ tre atme nt
• p re d nisone 50-100 mg (to cle ar) +/– ste roid sp aring age nts
such as azathiop rine
• te tracycline 500-1 000 mg/d ay +/– nicotinamid e is e ffe ctive for some case s
• d ap sone 100-150 mg/d ay for mild e r case s
DERMATITIS HERPETIFORMIS
❏ inte nse ly p ruritic group e d p ap ule s/ve sicle s/urticarial whe als
❏ e tiology
• 90% associate d with glute n se nsitive e nte rop athy (80% are asymp tomatic),
30% have thyroid d ise ase , and some have inte stinal lymp homa
• iron or folate d e ficie ncy
❏ history
• 20-60 ye ars old , M:F = 2:1
• 90% have HLA B8, DR3, DQW2
❏ p hysical
• site s: e xte nsor surface s of e lb ows/kne e s, sacrum, b uttocks, scalp
❏ d iagnosis
• immunofluore sce nce : granular IgA and comp le me nt d e p osition
in d e rmis
❏ course
• le sions last d ays - we e ks
❏ tre atme nt
• d ap sone for p ruritus b ut multip le sid e e ffe cts
• glute n fre e d ie t
tre atme nt high dose steroids moderate dose steroid gluten-free diet/dapsone
cyclophosphamide cyclophosphamide
Table 9. Comparis on of Erythe ma Multiforme , Ste ve ns -Johns on Syndrome and Toxic Epide rmal Ne crolys is
Erythe ma Multiforme (EM) Ste ve ns -Johns on Syndrome (SJS) Toxic Epide rmal
(s e e Colour Atlas A10) Ne colys is (TEN)
(s e e Colour Atlas A14)
Lesion • macules/papules with central vesicles • EM with more mucous membrane • severe mucous membrane involvement
• classic bull’s-eye pattern of concentric involvement, and blistering • “atypical lesions” – 50% have no target
light and dark rings (target lesions) • “atypical lesions” - red circular lesions
• bilateral and symmetric patch with dark purple center • diffuse erythema then necrosis and
• EM minor - no mucosal involvement, • more “sick” (high fever) sheet-like epidermal detachment in >30%
bullae, or systemic symptoms • sheet-like epidermal detachment in <10%
• EM major – mucosal involvement, bullae, • Nikolsky sign
systemic symptoms, usually drug induced
• Nikolsky sign (see pemphigus vulgaris)
Sites • mucous membrane involvement (oral, • generalized with prominent face and • generalized
genital, conjunctival) trunk involvement • nails may also shed
• extremities with face > trunk • palms and soles may be spared
• involvement of palms and soles
Other organs/ • corneal ulcers, keratitis, anterior uveitis, • complications: scarring, eruptive • tubular necrosis and acute renal failure,
complications stomatitis, vulvitis, balanitis nevomelanocytic nevi, corneal scarring, epithelial erosions of trachea, bronchi, GI
• lesions in trachea, pharynx, larynx blindness, phymosis and vaginal synechiae tract
Constitutional • fever, weakness, malaise • prodrome 1-3 days prior to eruption with • high fever > 38ºC
symptoms fever and flu-like illness
Etiology • drugs – sulfonamides, NSAIDs, • 50% are drug related • 80% are definitely drug related
anticonvulsants, penicillin, allopurinol • occurs up to 1-3 weeks after drug exposure • < 5% are due to viral infection,
• infection – herpes, mycoplasma with more rapid onset upon rechallenge immunization
• idiopathic - >50%
Pathology/ • perivascular PMN infiltrate, • cytotoxic cell-mediated attack on • same as Stevens-Johnson Syndrome
Pathophysiology edema of upper dermis epidermal cells
• no dermal infiltrate
• epidermal necrosis and detatchment above
basement membrane
Differential • EM minor – urticaria, viral exanthems • scarlet fever, phototoxic eruption, GVHD, • scarlet fever, phototoxic eruption, GVHD,
diagnosis • EM major – SSSS, pemphigus vulgaris, SSSS, exfoliative dermatitis SSSS, exfoliative dermatitis
bullous pemhigoid
Course and • lesions last 2 weeks • < 5% mortality • 30% mortality due to fluid loss,
Prognosis • regrowth of epidermis by 3 weeks secondary infection
Treatment • prevention – drug avoidance • withdraw suspect drug • admit to burn unit
• symptomatic treatment • intravenous fluids
• corticosteroids in severely ill • corticosteroids – controversial
but controversial • infection prophylaxis
DRUG ERUPTIONS
EXANTHEMATOUS ERUPTIONS
(MACULOPAPULAR ERUPTIONS/
MORBILLIFORM)
❏ symme trical, wid e sp re ad , e rythe matous p atche s or p laq ue s with
or without scale s
• the “classic” ad ve rse d rug re action
• ofte n starts on trunk or on are as of sun e xp osure
• may p rogre ss to ge ne ralize d e xfoliative d e rmatitis e sp e cially if
the d rug is continue d
• p e nicillin, sulfonamid e s, p he nytoin (in ord e r of d e cre asing p rob ab ility)
• incid e nce of amp icillin e rup tion is gre ate r than 50% in
p atie nts with mononucle osis, gout or chronic lymp hocytic
le uke mia
ANGIOEDEMA
❏ d e e p e r swe lling of the skin involving sub cutane ous tissue s ofte n with
swe lling of the e ye s, lip s, and tongue
❏ may or may not accomp any urticaria
❏ he re d itary Angioe d e ma - d oe s not occur with urticaria
• onse t in child hood ; 80% have p ositive family history
• re curre nt attacks; 25% d ie from laynge al e d e ma
• trigge rs: minor trauma, e motional up se t, te mp e rature change s
• d iagnosis: re d uce d C1 e ste rase inhib itor le ve l (in 85%) or function
(in 15%), d iminishe d C4 le ve l
❏ acq uire d angioe d e ma
• autoantib od ie s to C1 e ste rase inhib itor
• consump tion of comp le me nt in lymp hop rolife rative d isord e r
• d iagnosis: C1 e ste rase inhib itor d e ficie ncy, d e cre ase d C1
(uniq ue to acq uire d form), d iminishe d C4 le ve l
❏ tre atme nt: p rop hylaxIS with d anazol or stanozolol
• Ep rine p hrine p e n to te mp orize until p atie nt re ache s
hosp ital in acute attack
acute urticaria • Food s (nuts, she llfish, e ggs, fruits) • Attack lasts <6 we e ks
• Inse ct stings • Each le sion lasts <24 hrs
• Drugs (e sp e cially asp irin, NSAID’s) • Occurs with or without angioedema
• Contacts – cosme tics, work e xp osure s
• Infe ction – viral (he p atitis, up p e r re sp iratory), b acte rial, p arasitic
• Syste mic d ise ase s – SLE, e nd ocrinop athy (TSH), ne op lasm
• Stre ss
• Id iop athic
Choline rgic urticaria • Incre ase d core b od y te mp e rature • Tiny fle sh coloure d whe als with
• hot showe r, e xe rcise surround ing re d flare
Phyiscal urticarias
• Aq uage nic urticaria • e xp osure to wate r
• Cold urticaria • ice cub e , swimming p ool • Can b e life thre ate ning
• De rmograp hism • Friction, rub b ing skin • Imme d iate and p ossib le
d e laye d typ e s
• He at urticaria • local he at
• Pre ssure urticaria • Locate d ove r p re ssure are as of b od y (should e r strap , b uttocks) • Imme d iate and d e laye d typ e s
PHOTOSENSITIVITY ERUPTIONS
❏ p hototoxic re action: “an e xagge rate d sunb urn” confine d to light
e xp ose d are as
❏ p hotoalle rgic re action: an e cze matous e rup tion that may sp re ad to
are as not e xp ose d to light
❏ chlorp romazine , d oxycycline , thiazid e d iure tics, p rocainamid e
MCCQE 2000 Re vie w Note s and Le cture Se rie s De rmatology 23
DRUG ERUPTIONS . . . CONT. Note s
FIBROUS
De rmatofibroma
❏ firm, re d -b rown, solitary, we ll d e marcate d intra-d e rmal p ap ule s or
nod ule s with ce ntral d imp ling
❏ site : le gs
❏ unknown e tiology, ofte n with ante ce d e nt trauma or inse ct b ite s
❏ d imp le sign on p re ssure
❏ tre atme nt
• no tre atme nt usually ne e d e d (e xcise if b othe rsome )
❏ d iffe re ntial
• malignant me lanoma, ne vus
De rmatology 24 MCCQE 2000 Re vie w Note s and Le cture Se rie s
COMMON SKIN LESIONS . . . CONT. Note s
VASCULAR
He mangiomas
❏ b e nign p rolife ration of ve sse ls in the d e rmis
❏ tre atme nt op tions: argon lase r, tattooing, cosme tics, e xcision with skin e xp ansion
Acquired • early childhood to age 40 • benign neoplasm of pigment • excisional biopsy required if
Melanocytic Nevo Cellular Nevi • involute by age 60 forming nevus cells on scalp, soles, mucous membranes,
(MNCN) • well circumscribed, round, uniformly anogenital area, or has variegated
pigmented macules/papules colours, irregular borders, pruritic,
• <1.5 cm bleeding, exposed to trauma
• can be classified according to site
of nevus cells
- Junctional NCN • flat, irregularly bordered, uniformly • melanocytes at dermal-epidermal • same as above
tan-dark brown, sharply demarcated junction above basement membrane
macule
- Compound NCN • elevated, regularly bordered, uniformly • melanocytes at dermal-epidermal junction; • same as above
(s e e Colour Atlas A22) tan-dark brown papule migration into dermis
• NOT found on palms or soles
- Dermal NCN • soft, dome-shaped, skin-coloured to • melanocytes exclusively in dermis • same as above
tan/brown papules
• sites: face, neck
MCCQE 2000 Re vie w Note s and Le cture Se rie s
Clark’s Melanocytic Nevus • variegated macule/papule with irregular • follow q 2-6 months with colour
(Dysplastic Nevus) indistinct borders and focal elevation photographs
• >6 mm • excisional biopsy if lesion changing or
• RFs: postive family history highly atypical
100% lifetime risk with 2 blood relatives
with melanoma (0.7% risk for general
population)
Note s
Blue 1.5-40 • uniformly blue to blue-black • pigmented melanocytes and • remove if suddenly appears or has
macule/papule with smooth border melanophages in dermis changed
• < 6 mm
COMMON SKIN LESIONS . . . CONT. Note s
MISCELLANEOUS
Ke loid
❏ e xce ssive p rolife ration of collage n following trauma to skin, may
continue to e xp and in size for ye ars
• site s: e arlob e s, should e rs, ste rnum, scap ular are a
• p re d ile ction for Blacks and Orie ntals
❏ tre atme nt
• intrale sional ste roid inje ctions
• silicone comp re ssion
❏ d iffe re nt from a hyp e rtrop hic scar
Nodular Me lanoma
❏ atyp ical me lanocyte s that initially grow ve rtically with little late ral
sp re ad
❏ uniform, gre y-b lack, and sharp ly d e line ate d
❏ rap id ly fatal
❏ 30% of me lanomas
Tre atme nt
❏ e xcisional b iop sy p re fe rab le , othe rwise incisional b iop sy
❏ re move full d e p th of d e rmis and e xte nd b e yond e d ge s of le sion
only afte r histologic d iagnosis
❏ lymp h nod e d isse ction shows survival ad vantage if nod e s uninvolve d
❏ che mothe rap y (cis-p latinum, BCG) for stage II (re gional) and stage
III (d istant) d ise ase
❏ rad iothe rap y curative for uve al me lanomas, p alliative b one and b rain
me tastase s
OTHERS
Le ukoplakia
❏ white p atch/p laq ue on lowe r lip , floor of mouth, b uccal mucosa, tongue
b ord e r or re tromolarly
• 40-70 ye ars old , M > F, fair-skinne d
• p re malignant le sion arising from chronic irritation or inflammation
❏ tre atme nt
• e xcision
• cryothe rap y
❏ d iffe re ntial d iagnosis
• liche n p lanus
• oral hairy le ukop lakia
ICHTHYOSIS VULGARIS
❏ a ge ne ralize d d isord e r of hyp e rke ratosis le ad ing to d ry skin,
associate d with atop y and ke ratosis p ilaris
• “fish-scale ” ap p e arance e sp e cially on e xtre mitie s with sp aring of
fle xural cre ase s, p alms and sole s
• “2 A.D.”: atop ic d e rmatitis and autosomal d ominant
❏ tre atme nt
• imme rsion in b ath and oils
• e mollie nt or hume ctant cre ams and ointme nts containing ure a
NEUROFIBROMATOSIS
(NF; VON RECKLINGHAUSEN’S DISEASE)
❏ characte rize d b y cafe -au-lait macule s and ne urofib romas
• d iagnostic crite ria includ e
1) more than 6 cafe -au-lait sp ots > 1.5 cm in an ad ult, and
more than 5 cafe -au-lait sp ots > 0.5 cm in a child und e r age 5
2) axillary fre ckling
3) iris hamartomas (Lisch nod ule s)
4) op tic gliomas
5) ne urofib romas, and othe rs
• autosomal d ominant d isord e r with e xce ssive and
ab normal p rolife ration of ne ural cre st e le me nts
• associate d with p he ochromocytoma, astrocytoma,
b ilate ral acoustic ne uromas, b one cysts, scoliosis,
p re cocious p ub e rty
• follow close ly for malignancy
VITILIGO (s e e Colour Atlas A13)
❏ acq uire d loss of me lanocyte s characte rize d b y sharp ly marginate d off
white macule s or p atche s
• site s: e xte nsor surface s and p e riorificial are as (mouth, e ye s,
anus, ge nitalia)
• associate d with stre aks of d e p igme nte d hair, choriore tinitis
• 30% with +ve family history
• associate d with autoimmune d ise ase e sp e cially thyroid
• d o b lood work to rule out thyroid d ysfunction, p e rnicious
ane mia, Ad d ison’s d ise ase , d iab e te s
• Wood ’s lamp to d e te ct le sions in fair-skinne d p atie nts
❏ manage me nt
• camouflage make up (se lf-tanning p re p arations)
• PUVA (p sorale ns and UVA)
• minigrafting
• “b le aching” normal p igme nte d are as (total white colour)
• d one in wid e sp re ad loss of p igme ntation
• sun p rote ction
AUTOIMMUNE DISORDERS
syste mic lup us e rythe matosus malar e rythe ma, e rythe matous p ap ule s or p laq ue s on face , hand s, and arms, he morrhagic b ullae ,
p alp ab le p urp ura, urticarial p urp ura, p atchy/d iffuse alop e cia, mucosal ulce rs (s e e Colour Atlas L1)
cutane ous lup us e rythe matosus sharp ly marginate d b right re d p ap ule s and p laq ue s with ad he re nt scale s, te langie ctasia, marke d scarring,
scarring alop e cia
scle rod e rma Raynaud 's, nonp itting e d e ma, waxy/shiny/te nse atrop hic skin (morp he a), ulce rs, cutane ous calcification,
p e riungal te langie ctasia (s e e Colour Atlas L8)
d e rmatomyositis p e riorb ital he liotrop e with e d e ma, violace ous e rythe ma, Gottron's p ap ule s (violace ous flat-top p e d
p ap ule s with atrop hy), p e riungal e rythe ma, te langie ctasia, ulce rs (s e e Colour Atlas L2 and L4)
p olyarte ritis nod osa p olyarte ritic nod ule s, p urp ura, e rythe ma, gangre ne
rhe umatic fe ve r p e te chiae , urticaria, e rythe ma nod osum, e rythe ma multiforme , rhe umatic nod ule s
Bue rge r's d ise ase sup e rficial migraine thromb op hle b itis, p allor, cyanosis, gangre ne , ulce rations
ENDOCRINE DISORDERS
Cushing’s synd rome p urp le atrop hic striae , hyp e rp igme ntation, hyp e rtrichosis (s e e Colour Atlas B1)
hyp e rthyroid moist, warm skin with e vane sce nt e rythe ma, se b orrhe a, acne , nail atrop hy, hyp e rp igme ntation, toxic
alop e cia, localize d myxe d e ma of p re tib ial are a (s e e Colour Atlas B2 and B3)
hyp othyroid cool, d ry, scaly, thicke ne d , hyp e rp igme nte d skin; toxic alop e cia with d ull, d ry, coarse hair
Ad d ison’s d ise ase hyp e rp igme ntation on are as of friction and p re ssure
d iab e te s me llitus incre ase d incid e nce of skin infe ctions: b oils, carb uncle s, ulce rs, gangre ne , cand id iasis, tine a p e d is and
cruris, infe ctious e cze matoid d e rmatitis; othe r: p ruritus, xanthoma d iab e ticorum, ne crob iosis lip oid ica
d iab e ticorum (multicoloure d p ap ule s on ante rior shins) (s e e Colour Atlas B5)
HIV
viral HSV, HZV, HPV, molluscum contagiosum, oral hairy le ukop lakia
b acte rial imp e tigo, acne iform folliculitis, d e ntal carie s, ce llulitis, b acillary e p ithe lioid angiomatosis, syp hilis
malignancie s Kap osi’s Sarcoma (s e e Colour Atlas A20) , lymp homa, b asal ce ll carcinoma, sq uamous ce ll carcinoma,
malignant me lanoma
MALIGNANCY
Ad e nocarcinoma
GI Pe utz-Je ghe rs: p igme nte d macule s on lip s/oral mucosa
ce rvix/anus/re ctum Page t’s Dise ase : e rod ing scaling p laq ue s of p e rine um
Carcinoma
b re ast Page t’s Dise ase : e xze matous and crusting le sions of b re ast
GI Palmop lantar ke ratod e rma: thicke ne d skin of p alms/sole s
thyroid Sip p le ’s Synd rome : multip le mucosal ne uromas
b re ast/GU/lung/ovary De rmatomyositis: he liotrop e e rythe ma of e ye lid s and p urp lish p laq ue s ove r knuckle s
OTHERS
p ruritic urticaria p ap ule s and e rythe matous p ap ule s or urticarial p laq ue s in d istrib ution of striae d iste nsae , b uttocks, thighs,
p laq ue s of p re gnancy (PUPPP) up p e r inne r arms and lowe r b acks
cryoglob uline mia p alp ab le p urp ura in cold -e xp ose d are as, Raynaud 's, cold urticaria, acral he morrhagic ne crosis, b le e d ing
d isord e rs; re late d to he p atitis C infe ction
PRURITUS
❏ care ful history is imp ortant, b e cause me d ical workup may b e ind icate d
in 20% of case s
❏ cause s
• d e rmatologic - ge ne ralize d
• winte r itch (=xe rotic e cze ma, d ry and cracke d mainly le gs,
skin
• se nile p ruritus (may not have d ry skin, any time of ye ar)
• infe stations - scab ie s, lice
• d rug e rup tions - ASA, antid e p re ssants, op iate s
• p sychoge nic state s
• d e rmatologic - local
• atop ic and contact d e rmatitis, liche n p lanus,
urticaria, inse ct b ite s, d e rmatitis he rp e tiformis
• infe ction – varice lla, cand id iasis
• ne urod e rmatitis (liche n simp le x chronicus, vicious
cycle of itching & scratching le ad s to e xcoriate d
liche nifie d p laq ue s)
• me d ical - usually ge ne ralize d
• some typ e s of chole stasis (e .g. PBC, chlorp romazine ind uce d )
• chronic re nal failure , chole static live r d ise ase of p re gnancy
• he matologic - Hod gkin’s lymp homa, multip le mye loma,
p olycythe mia ve ra, mycosis fungoid e s, he machromatosis,
Fe d e ficie ncy
• carcinoma - lung, b re ast, gastric
• e nd ocrine - carcinoid , d iab e te s, hyp othyroid /thyrotoxicosis
• infe ctious - HIV, onchoce rciasis, trichinosis, e chinococcosis
❏ tre atme nt
• tre at und e rlying cause and itch (minimize irritation and scratching)
• top ical corticoste roid and antip uritics such as me nthol, camp hor
or p he nol
• syste mic antihistamine s - H1 b locke rs are most e ffe ctive
• avoid top ical anae sthe tics which may se nsitize the skin
Phys iological
❏ male -p atte rn alop e cia
• te mp oral are as p rogre ssing to ve rte x, e ntire scalp may b e b ald
• action of te stoste rone on hair follicle s
• e arly 20’s-30’s (fe male and roge ne tic alop e cia is
d iffuse and occurs in 40’s and 50’s)
❏ tre atme nt
• minoxid il lotion to re d uce rate of loss/p artial re storation
• sp ironolactone in wome n
• hair transp lant
• finaste rid e 1 mg/d in me n
Phys ical
❏ trichotillomania: imp ulse -control d isord e r characte rize d b y comp ulsive
hair p ulling with re sultant notice ab le hair loss
❏ traumatic (e .g. tight “corn-row” b raid ing of hair)
Te loge n Effluvium
❏ 15% of hair normally in re sting p hase , ab out to she d (te loge n)
• p ost-p artum, p ost-b irth control p ill, se ve re p hysical/me ntal
stre ss can all incre ase the numb e r of hairs in te loge n
• hair may she d up to 3 months afte r stimuli
• will re grow
De rmatology 32 MCCQE 2000 Re vie w Note s and Le cture Se rie s
ALOPECIA (HAIR LOSS) . . . CONT. Note s
Clinical Pe arl
❏ Scarring alope cia ne e ds to be biops ie d vs . nons carring which doe s not
ve nous wound at malleolus, stasis change, 1. local wound dressing: moist interactive healing
edema, previous venous injury 2. compression: preferably 4 layer
3. after wound heals, support stocking for life
ne urotropic wound at pressure point or 1. pressure downloading by using proper shoes or seats
secondary to unknown trauma 2. promote moist interactive wound healing
CHEMICAL PEELING
(Che me xfoliation, Che mical Re s urfacing)
❏ ap p lication of caustic age nt(s) to skin to p rod uce a controlle d
d e struction of e p id e rmis or d e rmis with sub se q ue nt
re -e p ithe liazation
❏ top ical ke ratolytics are ap p lie d 2-3 we e ks p re op e rative ly
❏ 3 d iffe re nt cate gorie s of che mical p e e ling age nts use d , d e p e nd ing on
the ir d e p th of cutane ous p e ne tration re q uire d :
Table 13.
❏ comp lications
• e rythe ma, infe ction, p ostinflammatory hyp e r/hyp op igme ntation,
hyp e rtrop hic scars
LASER THERAPY
❏ wave le ngth is inve rse ly p rop ortional to ab sorp tion and d ire ctly
p rop ortional to p e ne tration d e p th
❏ p urp ose : to re move /le sse n unwante d p igme ntation or vascular le sions
❏ he moglob in, wate r, and me lanin are the main targe ts of lase rs
❏ lase rs d e stroy unwante d skin ab normalitie s b ase d on 3 me chanisms
• he at e ne rgy – ab sorp tion of he at with 2º sp re ad to ad jace nt
tissue s
• me chanical e ne rgy – rap id the rmoe lastic e xp ansion d e stroys
targe t
• se le ctive p hotothe rmolysis – wave le ngth that is maximally
ab sorb e d b y targe t only and d oe s not sp re ad to ad jace nt tissue s
❏ comp lications
• e rythe ma, hyp e r/hyp op igme ntation, scars, infe ction
Face acne , rosace a, imp e tigo, contact d e rmatitis, lup us, actinic d e rmatitis, d e rmatomyositis,
se b orrhe ic d e rmatitis, folliculitis, le ntigo maligna me lanoma
he rp e s simp le x, BCC, SCC, actinic ke ratose s,
se b ace ous hyp e rp lasia
Pos te rior Ne ck ne urod e rmatitis (LSC), se b orrhe ic d e rmatitis, acne ke loid alis in b lack p atie nts
p soriasis, contact d e rmatitis
Mouth Ap hthae , he rp e s simp le x, ge ograp hic tongue , syp hilis, liche n p lanus, p e mp higus
contact d e rmatitis
Che s t and Back Tine a ve rsicolour, p ityriasis rose a, acne , se cond ary syp hilis, Grove r’s d ise ase ,
se b orrhe ic d e rmatitis, p soriasis, He rp e s Zoste r inve rse p soriasis
Pe nis Contact d e rmatitis, fusosp iroche tal and p rimary and se cond ary syp hilis,
cand id al b alanitis, chancroid , he rp e s simp le x, b alanitis xe rotica ob lite rans, liche n p lanus
Cond ylomata (HPV), scab ie s
Hands Contact d e rmatitis, d yshyd rotic e cze ma, p ustular p soriasis, granuloma annulare ,
re action to fungal infe ction of the fe e t e rythe ma multiforme , se cond ary syp hilis(p alms)
(one -hand two fe e t), warts, atop ic e cze ma, and fungal infe ction
p soriasis
Le gs Contact d e rmatitis, stasis d e rmatitis, ulce rs, p yod e rma gangre nosum, e rythe ma nod osum,
nummular e cze ma le ukocytoclastic vasculitis, HSP and othe r vasculitid ie s
VEHICLES
❏ for acute inflammation (e d e ma, ve siculation, oozing, crusting, infe ction)
use aq ue ous d rying p re p aration
❏ for chronic inflammation (scaling, liche nification, fissuring)
use a gre asie r, more lub ricating comp ound
Powde rs
❏ p romote d rying, incre ase skin surface are a (i.e . cooling)
• use d in inte rtriginous are as to re d uce moisture and friction
• ine rt or contain me d ication
Lotions
❏ susp e nsions of p owd e r in wate r
• cool and d ry as the y e vap orate
• le ave a uniform film of p owd e r on skin
• e asily ap p lie d to hirsute are as
Cre am
❏ se misolid e mulsions of oil in wate r
• wate r-solub le , contain e mulsifie rs and p re se rvative s
• cosme tically p le asing
Ge l
❏ transp are nt, colourle ss, se misolid e mulsion
• liq uifie s on contact with skin
• d rie s as a thin, gre ase le ss, nonocclusive , nonstaining film
• aq ue ous, ace tone , alcohol or p rop yle ne glycol b ase
Ointme nt
❏ se misolid wate r in oil e mulsions (more viscous than cre am)
• ine rt b ase s - p e trolatum
• most e ffe ctive to transp ort me d ications into skin
• re tain he at, imp e d e wate r loss, incre ase hyd ration
• occlusive , not to b e use d in oozing or infe cte d are as
TOPICAL STEROIDS
Table 16. Pote ncy Ranking of Topical Ste roids
Re lative Pote ncy Re lative Stre ngth Ge ne ric Name s Trade Name s Us age
SUNSCREENS AND
PREVENTATIVE THERAPY
UV Radiation
❏ UVA (320-400nm)
• p e ne trate s skin more e ffe ctive ly the n UVB or UVC
• re sp onsib le for tanning, b urning, wrinkling and
p re mature skin aging
• p e ne trate s cloud s, glass and is re fle cte d off wate r, snow and ce me nt
❏ UVB (290-320nm)
• ab sorb e d b y the oute r d e rmis
• is mainly re sp onsib le for b urning and p re mature skin aging
• p rimarily re sp onsib le for BCC, SCC and me lanomas
• d oe s not p e ne trate glass and is sub stantially ab sorb e d b y ozone
❏ UVC (200-290nm)
• is filte re d b y ozone laye r
Suns cre e ns
❏ SPF: und e r id e al cond itions a sun p rote ction factor of 10 me ans that a
p e rson who normally b urns in 20 minute s will b urn in 200 minute s
following the ap p lication of the sunscre e n, no matte r how ofte n the
sunscre e n is sub se q ue ntly ap p lie d
❏ Top ical Che mical: re q uire s ap p lication, at le ast 15-60 minute s p rior to
e xp osure
• UVB ab sorb e rs: PABA, Salicylate s, Cinnamate s, Be nzylid e ne
camp hor d e rivative s
• UVA ab sorb e rs: Be nzop he none s, Anthranilate s,
Dib e nzoylme thane s, Be nzylid e ne camp hor d e rivative s
• Top ical Physical: re fle cts and scatte rs UV light
• Titanium d ioxid e , Zinc oxid e , Kaolin, Talc, Fe rric chlorid e and
Me lanin all are e ffe ctive against the UVA and UVB sp e ctrum
• le ss risk of se nsitization the n che mical sunscre e ns and
wate rp roof, b ut may cause folliculitis or miliaria